Convergent Therapeutics Appoints Elizabeth L. Montgomery as Chief People Officer
Convergent Therapeutics, a clinical-stage biotech company developing radiopharmaceuticals for cancer treatment, announced the appointment of Elizabeth L. Montgomery as Chief People Officer on January 28, 2026.12
Montgomery joined the company this month and will serve on the executive leadership team, bringing over 20 years of experience in people strategy, talent development, change management, and organizational performance.1
Previously, she was CPO at Black Diamond Therapeutics and ClearView Healthcare Partners, and held roles at IQVIA and Boston Scientific; she holds an MBA from Babson College and a BS from Boston University.1
CEO Philip Kantoff stated her expertise is essential for scaling the organization ahead of Phase 3 studies for CONV01-α in metastatic castration-resistant prostate cancer.1
Montgomery expressed excitement about supporting Convergent's growth and mission in advancing prostate cancer treatments.1
Sources:
1. https://www.businesswire.com/news/home/20260128385906/en/Convergent-Therapeutics-Appoints-Elizabeth-L.-Montgomery-Chief-People-Officer